Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Human parechovirus infections in children: modern concepts
https://doi.org/10.21508/1027-4065-2023-68-5-5-10
Abstract
This article is a review of modern ideas about human parechovirus infection in children. At this time human parechoviruses are a common cause of infectious diseases in childhood with clinical presentation of acute gastroenteritis, upper respiratory tract pathology, fever, and rash. Severe forms damaging the central nervous system or the development of sepsis are possible in newborns and infants and are almost exclusively associated with parechovirus A type 3 (HPeV-A3). The infection is transmitted mainly via food and droplet routes. The main method of infection diagnosis is the detection of viral RNA by real-time PCR in cerebrospinal fluid, blood, and feces. No treatment for the parechovirus infection has been developed so far.
About the Authors
A. M. Sabitova
Kazan State Medical University
Russian Federation
Russian Federation
Kazan
V. A. Anokhin
Kazan State Medical University
Russian Federation
Russian Federation
Kazan
S. V. Khaliullina
Kazan State Medical University
Russian Federation
Russian Federation
Kazan
G. R. Fatkullina
Kazan State Medical University
Russian Federation
Russian Federation
Kazan
A. E. Evdokimova
Kazan State Medical University
Russian Federation
Russian Federation
Kazan
References
1. Tanaka S., Aoki Y., Matoba Y., Yahagi K., Itagaki T., Matsuzaki Y. et al. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014. Microbiol Immunol 2016; 60: 854–858. DOI: 10.1111/1348–0421.12456
2. Novikova N.A., Golycina L.N., Selivanova S.G., Zverev V.V., Ponomareva N.V., Leonov A.V. et al. Morbidity, etiological structure and issues of prevention of enterovirus (non-polio) infection. Information Bulletin of the Reference Center for Monitoring Enteroviral Infections. Scientific Research Institute of Epidimiology and Microbiology named after academician I.N. Blockin. Nizhniy Novgorod, 2022; 16. (in Russ.)
3. Wigand R., Sabin A.B. Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch 1961; 11: 224–247. DOI: 10.1007/BF01241688
4. Current ICTV Taxonomy Release [Электронный ресурс]. https://ictv.global/taxonomy / Ссылка активна на 11.07.2023.
5. Aizawa Y., Suzuki Y., Watanabe K., Oishi T., Saitoh A. Clinical utility of serum samples for human parechovirus type 3 infection in neonates and young infants: The 2014 epidemic in Japan. J Infect 2016; 72(2): 223–232. DOI: 10.1016/j.jinf.2015.10.010
6. Suthar P.P., Hughes K., Kadam G., Jhaveri M., Gaddikeri S. Human parechovirus meningoencephalitis. SA J Radiol 2023; 27(1): 2589. DOI: 10.4102/sajr.v27i1.2589
7. Ancora G., Faldella G., Chiereghin A., Marsico C., Nigro C.S., Lazzarotto T. et al. Parechovirus infection causing sepsis-like illness in newborns: a NICU approach. New Microbiol 2020; 43(3): 144–147
8. de Crom S.C., Rossen J.W., van Furth A.M., Obihara C.C. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr 2016; 175(8): 1023–1029. DOI: 10.1007/s00431–016–2725–7
9. Westerhuis B., Kolehmainen P., Benschop K., Nurminen N., Koen G., Koskiniemi M. et al. Human parechovirus seroprevalence in Finland and the Netherlands. J Clin Virol 2013; 58(1): 211–215. DOI: 10.1016/j.jcv.2013.06.036
10. Watanabe K., Hirokawa C., Tazawa T. Seropositivity and epidemiology of human parechovirus types 1, 3, and 6 in Japan. Epidemiol Infect 2016; 144(16): 3451–3460. DOI: 10.1017/S0950268816001795
11. Izumita R., Deuchi K., Aizawa Y., Habuka R., Watanabe K., Otsuka T., Saitoh A. Intrafamilial Transmission of Parechovirus A and Enteroviruses in Neonates and Young Infants. J Pediatric Infect Dis Soc 2019; 8(6): 501–506. DOI: 10.1093/jpids/piy079
12. Shah G., Robinson J.L. The particulars on parechovirus. Can J Infect Dis Med Microbiol 2014; 25(4): 186–188. DOI: 10.1155/2014/602501
13. Janes V.A., Minnaar R., Koen G., van Eijk H., Dijkman-de Haan K., Pajkrt D. et al. Presence of human non-polio enterovirus and parechovirus genotypes in an Amsterdam hospital in 2007 to 2011 compared to national and international published surveillance data: a comprehensive review. Euro Surveill 2014; 19(46): 20964. DOI: 10.2807/1560–7917
14. Abedi G.R., Watson J.T., Nix W.A., Oberste M.S., Gerber S.I. Enterovirus and Parechovirus Surveillance — United States, 2014–2016. MMWR Morb Mortal Wkly Rep 2018; 67(18): 515–518. DOI: 10.15585/mmwr.mm6718a2
15. Fan Y.M., Oikarinen S., Lehto K.M., Nurminen N., Juuti R., Mangani C. et al. High prevalence of selected viruses and parasites and their predictors in Malawian children. Epidemiol Infect 2019; 147: e90. DOI: 10.1017/S0950268819000025
16. Alam M.M., Khurshid A., Shaukat S., Rana M.S., Sharif S., Angez M. et al. Viral etiologies of acute dehydrating gastroenteritis in pakistani children: confounding role of parechoviruses. Viruses 2015; 7(1): 378–393. DOI: 10.3390/v7010378
17. Patil P.R., Ganorkar N.N., Gopalkrishna V. Epidemiology and genetic diversity of human parechoviruses circulating among children hospitalised with acute gastroenteritis in Pune, Western India: a 5-years study. Epidemiol Infect 2018; 146(1): 11–18. DOI: 10.1017/S095026881700262X
18. Faria N.R., de Vries M., van Hemert F.J., Benschop K., van der Hoek L. Rooting human parechovirus evolution in time. BMC Evol Biol 2009; 9: 164. DOI: 10.1186/1471–2148–9–164
19. Kolehmainen P., Siponen A., Smura T. Intertypic recombination of human parechovirus 4 isolated from infants with sepsis-like disease. J Clin Virol 2017; 88: 1–7. DOI: 10.1016/j.jcv.2017.01.001
20. Harvala H., Calvert J., Van Nguyen D., Clasper L., Gadsby N., Molyneaux P. et al. Comparison of diagnostic clinical samples and environmental sampling for enterovirus and parechovirus surveillance in Scotland, 2010 to 2012. Euro Surveill 2014; 19(15): 20772. DOI: 10.2807/1560–7917
21. Sridhar A., Karelehto E., Brouwer L., Pajkrt D., Wolthers K.C. Parechovirus A Pathogenesis and the Enigma of Genotype A-3. Viruses 2019; 11(11): 1062. DOI: 10.3390/v11111062
22. Shakeel S., Westerhuis B., Domanska A., Koning R., Matadeen R. Koster A.J. et al. Multiple capsid-stabilizing interactions revealed in a high-resolution structure of an emerging picornavirus causing neonatal sepsis. Nat Commun 2016; 7: 11387. DOI: 10.1038/ncomms11387
23. Midgley C.M., Jackson M.A., Selvarangan R., Franklin P., Holzschuh E.L., Lloyd J. et al. Severe Parechovirus 3 Infections in Young Infants-Kansas and Missouri, 2014. J Pediatric Infect Dis Soc 2018; 7(2): 104–112. DOI: 10.1093/jpids/pix010
24. Britton P.N., Khandaker G., Khatami A., Teutsch S., Francis S., McMullan B.J. et al. High prevalence of developmental concern amongst infants at 12 months following parechovirus infection. J Paediatr Child Health 2018; 54(3): 289–295. DOI: 10.1111/jpc.13728
25. Nejati A., Soheili P., Yousefipoor S., Zahraei S.M., Mahmoudi S., Yousefi M. et al. Molecular typing of enteroviruses and parechoviruses in acute flaccid paralysis patients in Iran in 2019. Arch Virol 2022; 167(3): 891–899. DOI: 10.1007/s00705–022–05359–0
26. Zhang M., Wu F., Liang M., Xian J., Zheng L., Li Q. et al. Parechovirus A infection and risk of gastroenteritis in children: A systematic review and meta-analysis. Rev Med Virol 2022; 32(6): e2380. DOI: 10.1002/rmv.2380
27. Zhirakovskaia E., Tikunov A., Babkin I., Tikunova N. Complete genome sequences of the first parechoviruses A associated with sporadic pediatric acute gastroenteritis in Russia. Infect Genet Evol 2020 80: 104214. DOI: 10.1016/j.meegid.2020
28. Danielski L.G., Giustina A.D., Badawy M., Barichello T., Quevedo J., Dal-Pizzol F. et al. Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis. Mol Neurobiol 2018; 55(2): 1045–1053. DOI: 10.1007/s12035–016–0356–7
29. Jan M.W., Su H.L., Chang T.H., Tsai K.J. Characterization of Pathogenesis and Inflammatory Responses to Experimental Parechovirus Encephalitis. Front Immunol 2021; 12: 753683. DOI: 10.3389/fimmu.2021.753683
30. Karelehto E., Cristella C., Yu X., Sridhar A., Hulsdouw R., de Haan K. et al. Polarized Entry of Human Parechoviruses in the Airway Epithelium. Front Cell Infect Microbiol. 2018; 8: 294. DOI: 10.3389/fcimb.2018.00294
31. Karelehto E., Wildenbeest J.G., Benschop K.S.M., Koen G., Rebers S., Bouma-de Jongh S. et al. Human Parechovirus 1, 3 and 4 neutralizing Antibodies in Dutch Mothers and Infants and Their Role in Protection Against Disease. Pediatr Infect Dis J 2018; 37(12): 1304–1308. DOI: 10.1097/INF.0000000000001986
32. Kurz H., Prammer R., Bock W., Ollerieth R., Bernert G., Zwiauer K. et al. Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna, Austria. Eur J Pediatr 2015; 174(12):1639–1647. DOI: 10.1007/s00431–015–2583–8
33. Recent Reports of Human Parechovirus (PeV) in the United States. [Электронный ресурс]. https://emergency.cdc.gov/han/2022/han00469.asp / Ссылка активна на 11.07.2023.
34. Wildenbeest J.G., Wolthers K.C., Straver B., Pajkrt D. Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant. Pediatrics 2013; 132(1): e243–7. DOI: 10.1542/peds.2012–1136
35. Rhoden E., Nix W.A., Weldon W.C., Selvarangan R. Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae). Antiviral Res 2018; 149: 75–77. DOI: 10.1016/j.antiviral.2017.11.011
36. Shakeel S., Westerhuis B.M., Ora A., Koen G., Bakker A.Q., Claassen Y. et al. Structural Basis of Human Parechovirus Neutralization by Human Monoclonal Antibodies. J Virol 2015; 89(18): 9571–9580. DOI: 10.1128/JVI
Review
For citations:
Sabitova A.M., Anokhin V.A., Khaliullina S.V., Fatkullina G.R., Evdokimova A.E. Human parechovirus infections in children: modern concepts. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2023;68(5):5-10. (In Russ.) https://doi.org/10.21508/1027-4065-2023-68-5-5-10
Views:
441
Email this article 